Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 24, 2026
Why Is Concentrix Corporation (CNXC) Stock Down -11% Today?

Why Is Concentrix Corporation (CNXC) Stock Down -11% Today?

Key Takeaways

  • Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open.
  • Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
  • Net income plunged 69.3% year-over-year, and operating income fell 29.8%, signaling severe profitability compression despite top-line growth.
  • Revenue of $2.50 billion grew 5.4% year-over-year but fell short of certain analyst estimates near $2.54 billion.
  • Full-year fiscal 2026 guidance was maintained, not raised — viewed by markets as lacking the upside surprise needed to justify the pre-earnings run-up.
  • Investors will be watching the 8:30 a.m. ET earnings call closely for management commentary on margin recovery and debt management.

Opening Summary

Concentrix Corporation (CNXC) is a global leader in customer experience (CX) management and technology-enabled business services, serving clients across industries including technology, financial services, retail, and healthcare. Shares are trading approximately 11% lower in Tuesday premarket activity, declining to roughly $28.05 from the prior session's close of approximately $31.52, following the release of disappointing fiscal Q1 2026 results.  While headline revenue grew year-over-year, the print revealed a dramatic deterioration in profitability that rattled investors — net income fell 69.3% versus the same period last year.  The earnings-driven selloff reflects deepening concerns about CNXC's margin trajectory in a highly competitive, cost-intensive CX landscape.

Earnings Miss on Profitability

Concentrix reported fiscal Q1 2026 revenue of $2,500.4 million, up 5.4% year-over-year from $2,372.2 million, but falling short of some analyst estimates pegged near $2.54 billion.   On the bottom line, adjusted diluted EPS of $2.61 missed the consensus of approximately $2.64 — a modest figure in isolation, but one that, when paired with the broader profitability collapse, intensified investor concern.  The slight top-line beat versus the company's own guidance range of $2.475–$2.500 billion offered little consolation given the scale of margin deterioration elsewhere in the report.

Profitability Under Severe Pressure

The most alarming figures came from within the income statement. Operating income fell 29.8% year-over-year to $118.6 million, compared with $168.9 million in Q1 2025.  Net income declined an even steeper 69.3%, a figure that markets viewed as alarming rather than temporary.  Adjusted EBITDA came in at $348.2 million versus $374.2 million in the prior-year period — a roughly 7% decline even in the company's most favorable profitability metric.  These figures reflect what management has framed as transition-related headwinds, including costs tied to its acquisition-integration program and an ongoing operational transformation.

Guidance: Maintained, Not Upgraded

Concentrix reiterated its full fiscal year 2026 outlook, maintaining non-GAAP diluted EPS guidance of $11.48 to $12.07 and revenue of $10.04 billion to $10.18 billion.  While guidance maintenance signals management's confidence in hitting full-year targets, it provided no upward revision to lift sentiment. This proved to be a critical disappointment: ahead of the report, CNXC shares had surged nearly 5% to $33.04 in early premarket trading, implying elevated investor expectations.  The sharp reversal after the results points to the market penalizing the company for failing to deliver any forward-looking catalyst alongside profitability weakness.

Market Context and Trading Activity

The sell-off arrives at a particularly vulnerable moment for CNXC shares, which entered today's session already down more than 20% year-to-date and approximately 50% below their 52-week high of $65.04, reached in early 2025.  The stock has experienced several significant single-session drops in recent months, including a 6.1% decline in mid-March and a 5.1% drop in early March, establishing a pattern of weak price action.   Today's gap-down is expected to bring dramatically elevated volume when the regular session opens, as the size of the premarket move will attract both liquidation by institutional holders and tactical interest from contrarian buyers. The broader technology and business services sector has not experienced similar pressure, reinforcing that this is a company-specific earnings event rather than a macro- or sector-driven move.

Trending AI Robots

For traders navigating volatile earnings moves like today's in CNXC, Tickeron's Trending AI Robots page offers a curated look at the platform's top-performing automated trading strategies. Tickeron operates hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this dedicated section. The bots vary by strategy type, risk profile, timeframe, and the specific symbols they trade — giving traders a data-driven starting point for finding approaches suited to today's environment. Whether you favor short-term momentum plays around earnings or more measured swing-trading strategies, exploring the Trending AI Robots page can help identify AI-driven strategies that align with your objectives.

What Comes Next for CNXC

The immediate focus shifts to the earnings conference call at 8:30 a.m. ET on March 24, where Concentrix management will need to address the scale of profitability deterioration and outline a credible path toward margin recovery.  Key investor questions will center on the speed of cost rationalization, the margin contribution of AI-enhanced CX services, and how the company plans to manage its leverage — with a debt-to-equity ratio near 1.67, interest expense remains a material drag.  Analysts currently maintain a consensus "Hold" rating with price targets well above current trading levels, reflecting a view that long-term value exists but near-term execution risk remains elevated.  Until CNXC demonstrates consistent improvement in operating and net margins over successive quarters, sentiment is likely to remain cautious. The next earnings report is expected in Q2 2026, and any upward guidance revision at that point would be a key potential re-rating catalyst.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CNXC

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CNXC in upward trend: price rose above 50-day moving average on August 19, 2026

CNXC moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend. In of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for CNXC crossed bullishly above the 50-day moving average on August 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CNXC advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

CNXC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 198 cases where CNXC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on August 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNXC as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CNXC turned negative on August 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNXC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.574) is normal, around the industry mean (7.110). P/E Ratio (8.576) is within average values for comparable stocks, (70.841). Projected Growth (PEG Ratio) (0.322) is also within normal values, averaging (1.226). CNXC's Dividend Yield (0.057) is considerably higher than the industry average of (0.025). P/S Ratio (0.157) is also within normal values, averaging (147.745).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CNXC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNXC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 9.37B. The market cap for tickers in the group ranges from 0 to 222.04B. IBM holds the highest valuation in this group at 222.04B. The lowest valued company is ARSC at 0.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 0%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 19%. JFU experienced the highest price growth at 30%, while WYFI experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was 6%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 63
Price Growth Rating: 57
SMR Rating: 72
Profit Risk Rating: 93
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
CNXC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of active thermal coal operations

Industry InformationTechnologyServices

Profile
Details
Industry
Coal
Address
39899 Balentine Drive
Phone
+1 800 747-0583
Employees
455000
Web
https://www.concentrix.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.